Description

Likopid tablets 1 mg, #10

Likopid is produced in tablet form. The active ingredient is glucosaminylmuramyl dipeptide.

Pharmacological Effect

Immunomodulating element. In cases of secondary immunodeficiencies, at a dosage of 1-10 mg, it stimulates the functional activity of phagocytic cells, as well as cellular and humoral factors of local and systemic immunity. For autoimmune diseases, doses of 10-20 mg inhibit the synthesis of cytokines involved in inflammatory processes.

Use in the Sports Sphere

In conditions of high physical and mental stress experienced by athletes, the immune system is the first to suffer. Therefore, the prevention and correction of sports-related immunodeficiency is an important task in sports medicine. This paper presents the results of a four-year study on the immune status of combat athletes (conducted five times a year) and the effectiveness of targeted immunotherapy. The study demonstrated that T-cell immunodeficiencies most often occur in athletes, correlating with the intensity of the training-competitive schedule and the season (autumn-winter). The proposed immunotherapy regimen promoted the normalization of immune profile indicators in athletes and effectively mitigated the consequences of high training and competitive loads.

Indications and Usage

Likopid is indicated for immunodeficiency, accompanied by chronic, sluggish, recurrent infectious, and inflammatory processes (as part of combination therapy), for both adults and children.

Method of Use and Dosage

Sublingual administration. For chronic infections of the upper and lower respiratory tract in the acute stage, take 1-2 mg once a day for 10 days, orally, 30 minutes before meals. For chronic infections of the upper and lower respiratory tract in remission, take 5-10 mg once a day for 10 days. To prevent postoperative complications, take 1 mg once a day for 5-10 days before surgery. For the treatment of severe forms of purulent septic processes of the skin and soft tissues, take 10 mg once a day for 10 days. For children, it is available only in tablet form (1 mg).

Contraindications

Likopid should not be prescribed to patients with hypersensitivity to glucosaminylmuramyl dipeptide. The medication is contraindicated for patients with galactosemia, lactase deficiency, and glucose-galactose malabsorption syndrome. It should also not be prescribed to patients with a body temperature of 38°C and higher, as well as those suffering from exacerbation stage of autoimmune thyroiditis. The medication is not suitable for children under the age of 3, lactating, and pregnant women.

Use During Pregnancy and Lactation

Likopid is not recommended for use in pregnant and lactating women.

Overdosage

There are no reported cases of overdosage with Likopid.

Side Effects

Taking Likopid may cause a slight increase in body temperature and the development of allergic reactions in some patients. If you experience unusual symptoms while taking the medication that are not described in the instructions, it is recommended to consult your doctor regarding further intake of Likopid.

Medication Interactions

Simultaneous use with Likopid can increase the clinical efficacy of antimicrobial, antiviral, and antifungal medications.

Special Instructions

Prescribing Likopid as part of a comprehensive therapy plan can enhance the effectiveness of antimicrobial, antifungal, and antiviral treatments, while reducing the duration of treatment.

Storage Terms and Conditions

Likopid should be stored in a place protected from moisture and sunlight. The shelf life is 5 years.

---

Likopid in the complex immunomodulating treatment of patients with sarcoidosis of the lung and intrathoracic lymph nodes